In UK practice, NICE guidance recognises these benefits, though SGLT2 inhibitors are typically prioritised for cardiorenal protection, with GLP-1 receptor agonists with proven cardiovascular benefit considered when SGLT2 inhibitors are unsuitable
Building on these tools, new dual agonist fluorescent probes such as daLUXendins enable the simultaneous investigation of GLP1R and GIPR (glucose-dependent insulinotropic polypeptide receptor), a critical advancement for studies on multi-agonist therapeutics in diabetes and obesity
Understanding tirzepatide Tirzepatide, also known by the brand names Mounjaro and Zepbound, is an FDA-approved dual-action GLP-1/GIP receptor agonist made by Eli Lilly
The risk of respiratory failure also showed no significant difference (RR 0.929, 95% CI 0.6891.253, p = 0.6299)
In fact, the FDA warns that at least until further review, they should only be used in official research settings [16]